Resveratrol-Induced Apoptosis and Increased Radiosensitivity in CD133-Positive Cells Derived From Atypical Teratoid/Rhabdoid Tumor

International Journal of Radiation Oncology Biology Physics

Volumn 74, Issue 1, 2009, Pages 219-228

  Kao, Chung Lan ^a   Huang, Pin I ^a   Tsai, Ping Hsing ^a   Tsai, Ming Long ^a   Lo, Jeng Fan ^a   Lee, Yi Yen ^a,b   Chen, Yann Jang ^a,b   Chen, Yi Wei ^a   Chiou, Shih Hwa ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI CITY HOSPITAL   (Taiwan)

Author keywords

Apoptosis; Atypical teratoid rhabdoid tumor; CD133; Ionizing radiation; Resveratrol

Indexed keywords

AFTER TREATMENTS; ANTI-PROLIFERATIVE; APOPTOSIS; APOPTOTIC ACTIVITIES; ATYPICAL TERATOID/RHABDOID TUMOR; BRAIN TUMORS; CD133; CHEMOTHERAPEUTIC AGENTS; CLINICAL TREATMENTS; COEXPRESSED; COLONY FORMATIONS; IN-VITRO; IN-VIVO; INDUCED APOPTOSIS; KAPLAN-MEIER; PROLIFERATION RATES; RESISTANT GENES; RESVERATROL; REVERSE TRANSCRIPTION-POLYMERASE CHAIN REACTIONS; STEM CELLS; SURVIVAL ANALYSIS; SURVIVAL RATES; XENOTRANSPLANTATION;

CELL DEATH; CRYOGENIC LIQUIDS; FLOW CYTOMETRY; GENES; IONIZING RADIATION; ONCOLOGY; PUMPS; RADIATION SHIELDING; RADIOACTIVITY; TRANSCRIPTION;

TUMORS;

BREAST CANCER RESISTANCE PROTEIN; CD133 ANTIGEN; CISPLATIN; DOXORUBICIN; ETOPOSIDE; MULTIDRUG RESISTANCE PROTEIN 1; MYC PROTEIN; NESTIN; OCTAMER TRANSCRIPTION FACTOR 4; PROTEIN OCT 4A; RESVERATROL; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER STEM CELL; CANCER SURVIVAL; CELL DIFFERENTIATION; CELL MIGRATION; CELL RENEWAL; COLONY FORMATION; CONTROLLED STUDY; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; IONIZING RADIATION; KAPLAN MEIER METHOD; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RADIOSENSITIVITY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHABDOID TUMOR; SURVIVAL RATE; TERATOMA; XENOTRANSPLANTATION;

ANIMALS; ANTIGENS, CD; ANTIGENS, NEOPLASM; APOPTOSIS; CELL PROLIFERATION; GLYCOPROTEINS; HUMANS; MICE; MICE, INBRED BALB C; MICE, SCID; PEPTIDES; RADIATION TOLERANCE; RADIATION-SENSITIZING AGENTS; RHABDOID TUMOR; STILBENES; TERATOMA; TUMOR MARKERS, BIOLOGICAL;

EID: 64049084289     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2008.12.035     Document Type: Article

References (37)

1. Rorke L.B., Packer R.J., and Biegel J.A. Central nervous system atypical teratoid/rhabdoid tumors of infancy and childhood: definition of an entity. J Neurosurg 85 (1996) 56-65
2. Burger P.C., Yu I.T., Tihan T., et al. Atypical teratoid/rhabdoid tumor of the central nervous system: A highly malignant tumor of infancy and childhood frequently mistaken for medulloblastoma: a Pediatric Oncology Group study. Am J Surg Pathol 22 (1998) 1083-1092
3. Tekautz T.M., Fuller C.E., Blaney S., et al. Atypical teratoid/rhabdoid tumors (ATRT): Improved survival in children 3 years of age and older with radiation therapy and high-dose alkylator-based chemotherapy. J Clin Oncol 23 (2005) 1491-1499
4. Packer R.J., Biegel J.A., Blaney S., et al. Atypical teratoid/rhabdoid tumor of the central nervous system: Report on workshop. J Pediatr Hematol Oncol 24 (2002) 337-342
5. Parwani A.V., Stelow E.B., Pambuccian S.E., et al. Atypical teratoid/rhabdoid tumor of the brain: Cytopathologic characteristics and differential diagnosis. Cancer 105 (2005) 65-70
6. Biegel J.A., Burk C.D., Parmiter A.H., et al. Molecular analysis of a partial deletion of 22q in a central nervous system rhabdoid tumor. Genes Chromosomes Cancer 5 (1992) 104-108
7. Biegel J.A., Zhou J.Y., Rorke L.B., et al. Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors. Cancer Res 59 (1999) 74-79
8. Versteege I., Sevenet N., Lange J., et al. Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer. Nature 394 (1998) 203-206
9. Weiss E., Behring B., Behnke J., et al. Treatment of primary malignant rhabdoid tumor of the brain: Report of three cases and review of the literature. Int J Radiat Oncol Biol Phys 41 (1998) 1013-1019
10. Hilden J.M., Meerbaum S., Burger P., et al. Central nervous system atypical teratoid/rhabdoid tumor: Results of therapy in children enrolled in a registry. J Clin Oncol 22 (2004) 2877-2884
11. Chen Y.W., Wong T.T., Ho D.M., et al. Impact of radiotherapy for pediatric CNS atypical teratoid/rhabdoid tumor (single institute experience). Int J Radiat Oncol Biol Phys 64 (2006) 1038-1043
12. Hemmati H.D., Nakano I., Lazareff J.A., et al. Cancerous stem cells can arise from pediatric brain tumors. Proc Natl Acad Sci U S A 100 (2003) 15178-15183
13. Singh S.K., Hawkins C., Clarke I.D., et al. Identification of human brain tumour initiating cells. Nature 432 (2004) 396-401
14. Neuzil J., Stantic M., Zobalova R., et al. Tumour-initiating cells vs. cancer ′stem′ cells and CD133: What's in the name?. Biochem Biophys Res Commun 355 (2007) 855-859
15. Ricci-Vitiani L., Lombardi D.G., Pilozzi E., et al. Identification and expansion of human colon-cancer-initiating cells. Nature 445 (2007) 111-115
16. Blazek E.R., Foutch J.L., and Maki G. Daoy medulloblastoma cells that express CD133 are radioresistant relative to CD133- cells, and the CD133+ sector is enlarged by hypoxia. Int J Radiat Oncol Biol Phys 67 (2007) 1-5
17. Bao S., Wu Q., McLendon R.E., et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444 (2006) 756-760
18. Chiou S.H., Kao C.L., Chen Y.W., et al. Identification of CD133-positive radioresistant cells in atypical teratoid/rhabdoid tumor. PLoS ONE 3 (2008) e2090
19. Das S., and Das D.K. Anti-inflammatory responses of resveratrol. Inflamm Allergy Drug Targets 6 (2007) 168-173
20. Bradamante S., Barenghi L., and Villa A. Cardiovascular protective effects of resveratrol. Cardiovasc Drug Rev 22 (2004) 169-188
21. de la Lastra C.A., and Villegas I. Resveratrol as an anti-inflammatory and anti-aging agent: Mechanisms and clinical implications. Mol Nutr Food Res 49 (2005) 405-430
22. Atten M.J., Godoy-Romero E., Attar B.M., et al. Resveratrol regulates cellular PKC alpha and delta to inhibit growth and induce apoptosis in gastric cancer cells. Invest New Drugs 23 (2005) 111-119
23. Kuo P.L., Chiang L.C., and Lin C.C. Resveratrol-induced apoptosis is mediated by p53-dependent pathway in Hep G2 cells. Life Sci 72 (2002) 23-34
24. Roccaro A.M., Leleu X., Sacco A., et al. Resveratrol exerts antiproliferative activity and induces apoptosis in Waldenstrom's macroglobulinemia. Clin Cancer Res 14 (2008) 1849-1858
25. Johnson G.E., Ivanov V.N., and Hei T.K. Radiosensitization of melanoma cells through combined inhibition of protein regulators of cell survival. Apoptosis 13 (2008) 790-802
26. Baatout S., Derradji H., Jacquet P., et al. Enhanced radiation-induced apoptosis of cancer cell lines after treatment with resveratrol. Int J Mol Med 13 (2004) 895-902
27. Kao C.L., Chiou S.H., Chen Y.J., et al. Increased expression of osteopontin gene in atypical teratoid/rhabdoid tumor of the central nervous system. Mod Pathol 18 (2005) 769-778
28. Lin H.Y., Tang H.Y., Keating T., et al. Resveratrol is pro-apoptotic and thyroid hormone is anti-apoptotic in glioma cells: Both actions are integrin and ERK mediated. Carcinogenesis 29 (2008) 62-69
29. Zeppernick F., Ahmadi R., Campos B., et al. Stem cell marker CD133 affects clinical outcome in glioma patients. Clin Cancer Res 14 (2008) 123-129
30. Beier D., Wischhusen J., Dietmaier W., et al. CD133 expression and cancer stem cells predict prognosis in high-grade oligodendroglial tumors. Brain Pathol 18 (2008) 370-377
31. Jordan C.T., Guzman M.L., and Noble M. Cancer stem cells. N Engl J Med 355 (2006) 1253-1261
32. Ben-Porath I., Thomson M.W., Carey V.J., et al. An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat Genet 40 (2008) 499-507
33. Chiou S.H., Yu C.C., Huang C.Y., et al. Positive correlations of Oct-4 and Nanog in oral cancer stem-like cells and high-grade oral squamous cell carcinoma. Clin Cancer Res 14 (2008) 4085-4095
34. Ezeh U.I., Turek P.J., Reijo R.A., et al. Human embryonic stem cell genes OCT4, NANOG, STELLAR, and GDF3 are expressed in both seminoma and breast carcinoma. Cancer 104 (2005) 2255-2265
35. Liao H.F., Kuo C.D., Yang Y.C., et al. Resveratrol enhances radiosensitivity of human non-small cell lung cancer NCI-H838 cells accompanied by inhibition of nuclear factor-kappa B activation. J Radiat Res (Tokyo) 46 (2005) 387-393
36. Ivanov V.N., Partridge M.A., Johnson G.E., et al. Resveratrol sensitizes melanomas to TRAIL through modulation of antiapoptotic gene expression. Exp Cell Res 314 (2008) 1163-1176
37. Chakraborty P.K., Mustafi S.B., Ganguly S., et al. Resveratrol induces apoptosis in K562 (chronic myelogenous leukemia) cells by targeting a key survival protein, heat shock protein 70. Cancer Sci 99 (2008) 1109-1116